Search
for
Sort by
Research 121–150 of 429
- Reporting on Adverse Clinical Events
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Functional analysis of the PIP5K1A gene in Liaoning Cashmere goats: an investigation based on bioinformatics, tissue localization, and biological functions
- POSTĘP W DIAGNOZIE I LECZENIU STWARDNIENIA ROZSIANEGO
- PŁYNY- NIE ZA DUŻO, NIE ZA MAŁO, LECZ W SAM RAZ
- ONKOLOGIA OKULISTYCZNA WCZORAJ I DZIŚ
- AUTOLOGOUS FAT GRAFTING UPDATE. PRESENTATION OF OWN RESULTS IN FACIAL REGENERATION
- MICRO-URZĄDZENIA, BEZPRZEWODOWE KAPSUŁKI, MAPY, STYMULATORY I ROZRUSZNIKI STOSOWANE DO DIAGNOSTYKI I LECZENIA ZABURZEŃ MOTORYKI PRZEWODU POKARMOWEGO
- EFFECTS OF LIRAGLUTIDE ON VISCERAL ADIPOSITY INDEX IN WOMAN OF REPRODUCTIVE AGE WITH PREDIABETES
- THE USE OF AN IMMUNOMODULATOR WITH AN ANTISEPTIC IN THE TREATMENT OF INFECTED AND PURULENT WOUNDS IN AN EXPERIMENT
- 1994 Forthcoming educational events
- Stem Cells and Their Niches
- Regulation of microvascular permeability by vascular endothelial growth factors
- In vivo skin leptin modulation after 14 MeV neutron irradiation: a molecular and FT-IR spectroscopic study
- Endoplasmic reticulum in health and disease: the 12th International Calreticulin Workshop, Delphi, Greece
- The Mammalian Hairless Protein as a DNA Binding Phosphoprotein
- Isoginkgetin, a natural biflavonoid from Ginkgo biloba, inhibits inflammatory response in endothelial cells via suppressing NF-κB activation
- Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas
- Finasteride Alleviates High Fat Associated Protein-Overload Nephropathy by Inhibiting Trimethylamine N-Oxide Synthesis and Regulating Gut Microbiota
- The Promoting Effect of Rosemary Oil on Hair Growth by Gross and Histological Observation in C57BL/6 Mice
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Persistent radiation-induced alopecia in patients with central nervous system tumors and head and neck sarcomas.
- 138: Induction of cellular senescence and hair follicle stem cell dysfunction upon p14ARF and p16Ink4a expression in the skin
- Abstract CN06-04: The hedgehog signaling pathway in cancer.
- C57BL/6 마우스에서 로즈마리 오일의 육안적, 조직학적 모발성장 촉진효과
- Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
- Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
- The JAK/STAT signaling pathway: from bench to clinic
- EMT Factors and Metabolic Pathways in Cancer